BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21544156)

  • 1. [Safety of the proton pump inhibitors].
    Oscanoa Espinoza TJ
    Rev Gastroenterol Peru; 2011; 31(1):49-55. PubMed ID: 21544156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton pump inhibitors: are they overutilised in clinical practice and do they pose significant risk?
    Heidelbaugh JJ; Metz DC; Yang YX
    Int J Clin Pract; 2012 Jun; 66(6):582-91. PubMed ID: 22607510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a dark side to long-term proton pump inhibitor therapy?
    Nealis TB; Howden CW
    Am J Ther; 2008; 15(6):536-42. PubMed ID: 19127138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton pump inhibitors in GORD An overview of their pharmacology, efficacy and safety.
    Savarino V; Di Mario F; Scarpignato C
    Pharmacol Res; 2009 Mar; 59(3):135-53. PubMed ID: 18977444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term acid inhibition: benefits and harms.
    Tepeš B
    Dig Dis; 2011; 29(5):476-81. PubMed ID: 22095013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gradual cessation of proton pump inhibitor (PPI) treatment may prevent rebound acid secretion, measured by the alkaline tide method, in dyspepsia and reflux patients.
    Niv Y
    Med Hypotheses; 2011 Sep; 77(3):451-2. PubMed ID: 21723045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus.
    Johnson DA; Katz PO; Armstrong D; Cohen H; Delaney BC; Howden CW; Katelaris P; Tutuian RI; Castell DO
    Drugs; 2017 Apr; 77(5):547-561. PubMed ID: 28233274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton Pump Inhibitors: Risks and Rewards and Emerging Consequences to the Gut Microbiome.
    Singh A; Cresci GA; Kirby DF
    Nutr Clin Pract; 2018 Oct; 33(5):614-624. PubMed ID: 30071147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic use of proton pump inhibitors: is the risk of osteoporosis and fractures real?].
    Martí-Cabrera M; Martí-Masanet M; Esplugues JV
    Gastroenterol Hepatol; 2011 Apr; 34(4):271-7. PubMed ID: 21419526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gastric acid rebound after a proton pump inhibitor: Narrative review of literature].
    Rochoy M; Dubois S; Glantenet R; Gautier S; Lambert M
    Therapie; 2018; 73(3):237-246. PubMed ID: 29195714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitors, osteoporosis, and osteoporosis-related fractures.
    Fournier MR; Targownik LE; Leslie WD
    Maturitas; 2009 Sep; 64(1):9-13. PubMed ID: 19674854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review: Rebound acid hypersecretion after therapy with proton pump inhibitors.
    Hunfeld NG; Geus WP; Kuipers EJ
    Aliment Pharmacol Ther; 2007 Jan; 25(1):39-46. PubMed ID: 17229219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acid inhibition and the acid rebound effect.
    Lerotić I; Baršić N; Stojsavljević S; Duvnjak M
    Dig Dis; 2011; 29(5):482-6. PubMed ID: 22095014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antisecretory potential of pantoprasole (sanpraz)].
    Kurilovich SA; Chernosheĭkina LE
    Eksp Klin Gastroenterol; 2008; (7):119-22. PubMed ID: 19334455
    [No Abstract]   [Full Text] [Related]  

  • 15. Do PPIs have long-term side effects? Nexium and the other proton-pump inhibitors are great at reducing stomach acid, but that might have some unintended consequences.
    Harv Health Lett; 2009 Jan; 34(3):4-5. PubMed ID: 19172761
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of proton pump inhibitors in preventing hypergastrinemia-associated carcinogenesis and in antagonizing the trophic effect of gastrin.
    Han YM; Park JM; Kangwan N; Jeong M; Lee S; Cho JY; Ko WJ; Hahm KB
    J Physiol Pharmacol; 2015 Apr; 66(2):159-67. PubMed ID: 25903947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Side Effects of Long-Term Proton Pump Inhibitor Use: A Review.
    Haastrup PF; Thompson W; Søndergaard J; Jarbøl DE
    Basic Clin Pharmacol Toxicol; 2018 Aug; 123(2):114-121. PubMed ID: 29658189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rebound acid hypersecretion after withdrawal of gastric acid suppressing drugs: new evidence of similitude.
    Teixeira MZ
    Homeopathy; 2011 Jul; 100(3):148-56. PubMed ID: 21784332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overuse of proton pump inhibitors.
    Ksiądzyna D; Szeląg A; Paradowski L
    Pol Arch Med Wewn; 2015; 125(4):289-98. PubMed ID: 25790817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk of long-term treatment with proton pump inhibitors].
    Mathieu N
    Rev Prat; 2008 Sep; 58(13):1451-4. PubMed ID: 18924330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.